Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 130

Results For "LTI"

2713 News Found

Aster to separate its India and GCC businesses to unlock value
News | November 29, 2023

Aster to separate its India and GCC businesses to unlock value

Both the India and GCC entities will be operated by separate dedicated management teams


Surgeons at Aster RV Hospitals achieve milestone with removal of 345 gallstones
Healthcare | November 28, 2023

Surgeons at Aster RV Hospitals achieve milestone with removal of 345 gallstones

This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones


BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement
Digitisation | November 28, 2023

BrainSpec receives FDA clearance to begin using AI-backed solution for non-invasive brain chemistry measurement

First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease


GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep
News | November 28, 2023

GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep

Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex


DxVx plans to make a license-in agreement of OVM-200
News | November 25, 2023

DxVx plans to make a license-in agreement of OVM-200

Final stage in licensing OVM-200 from Oxford Vacmedix in the UK


Merck to acquire Caraway Therapeutics
News | November 23, 2023

Merck to acquire Caraway Therapeutics

Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases


Fosun Pharma USA and Treehill Partners to invest in biopharma space
News | November 23, 2023

Fosun Pharma USA and Treehill Partners to invest in biopharma space

The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market


Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer
Drug Approval | November 22, 2023

Truqap plus Faslodex approved in the US for patients with advanced HR-positive breast cancer

First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients


LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices
Digitisation | November 21, 2023

LTTS, NVIDIA to unveil Gen AI and software defined architecture for medical devices

This innovative solution comes as an answer to the industry-wide challenges of availability, cost, and dependencies linked to custom and proprietary hardware components